Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses

Resistance to several prevalent infectious diseases requires both cellular and humoral immune responses. T cell immunity is initiated by mature dendritic cells (DCs) in lymphoid organs, whereas humoral responses to most antigens require further collaboration between primed, antigen-specific helper T cells and naive or memory B cells. To determine whether antigens delivered to DCs in lymphoid organs induce T cell help for antibody responses, we targeted a carrier protein, ovalbumin (OVA), to DCs in the presence of a maturation stimulus and assayed for antibodies to a hapten, (4-hydroxy-3-nitrophenyl) acetyl (NP), after boosting with OVA-NP. A single DC-targeted immunization elicited long-lived T cell helper responses to the carrier protein, leading to large numbers of antibody-secreting cells and high titers of high-affinity antihapten immunoglobulin Gs. Small doses of DC-targeted OVA induced higher titers and a broader spectrum of anti-NP antibody isotypes than large doses of OVA in alum adjuvant. Similar results were obtained when the circumsporozoite protein of Plasmodium yoelii was delivered to DCs. We conclude that antigen targeting to DCs combined with a maturation stimulus produces broad-based and long-lived T cell help for humoral immune responses.

• Publication year

  2006

• Venue

  Journal of Experimental Medicine

• Publication date

  2006-03-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1084/jem.20051639PMID 16505139PMCID 2118236
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inducing and expanding regulatory T cell populations by foreign antigen

  2005cited by this paper
• Dendritic cells as therapeutic vaccines against cancer

  2005cited by this paper
• In Vivo Targeting of Antigens to Maturing Dendritic Cells via the DEC-205 Receptor Improves T Cell Vaccination

  2004cited by this paper
• Immunological unresponsiveness characterized by increased expression of CD5 on peripheral T cells induced by dendritic cells in vivo.

  2004cited by this paper
• Modulating vaccine responses with dendritic cells and Toll‐like receptors

  2004cited by this paper
• Phase I Testing of a Malaria Vaccine Composed of Hepatitis B Virus Core Particles Expressing Plasmodium falciparum Circumsporozoite Epitopes

  2004cited by this paper
• Antigen presentation and T cell stimulation by dendritic cells.

  2002cited by this paper
• Inaugural Article : avoiding horror autotoxicus. The importance of dendritic cells in peripheral T cell tolerance

  2002cited by this paper
• Efficient Targeting of Protein Antigen to the Dendritic Cell Receptor DEC-205 in the Steady State Leads to Antigen Presentation on Major Histocompatibility Complex Class I Products and Peripheral CD8+ T Cell Tolerance

  2002cited by this paper
• Exploiting dendritic cells to improve vaccine efficacy.

  2002cited by this paper
• Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance

  2002cited by this paper
• Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo

  2001cited by this paper
• Regulation of T cell immunity by dendritic cells.

  2001cited by this paper
• A Potent Cross-Clade Neutralizing Human Monoclonal Antibody against a Novel Epitope on gp41 of Human Immunodeficiency Virus Type 1

  2001cited by this paper
• Swift Development of Protective Effector Functions in Naive Cd8+ T Cells against Malaria Liver Stages

  2001cited by this paper
• Molecular processes that regulate class switching.

  2000cited by this paper
• Immunobiology of dendritic cells.

  2000cited by this paper
• Functions of CD40 on B cells, dendritic cells and other cells.

  1997cited by this paper
• Standard Fmoc protocols.

  1997cited by this paper
• A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group.

  1997cited by this paper
• Plasmodium yoelii: peptide immunization induces protective CD4+ T cells against a previously unrecognized cryptic epitope of the circumsporozoite protein.

  1996cited by this paper
• Phenotypic Analysis of Antigen-Specific T Lymphocytes

  1996cited by this paper
• Clonal selection and learning in the antibody system

  1996cited by this paper
• Matrix-assisted laser desorption ionization mass-spectrometry of proteins.

  1996cited by this paper
• Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG

  1995cited by this paper
• Influenza and vaccinia viruses expressing malaria CD8+ T and B cell epitopes. Comparison of their immunogenicity and capacity to induce protective immunity.

  1994cited by this paper
• A Broadly Neutralizing Human Monoclonal Antibody against gp41 of Human Immunodeficiency Virus Type 1

  1994cited by this paper
• In situ studies of the antigen-driven somatic hypermutation of immunoglobulin genes.

  1992cited by this paper
• CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria.

  1991cited by this paper
• Sites of specific B cell activation in primary and secondary responses to T cell‐dependent and T cell‐independent antigens

  1991cited by this paper
• Monoclonal, but not polyclonal, antibodies protect against Plasmodium yoelii sporozoites.

  1991cited by this paper
• Inability of malaria vaccine to induce antibodies to a protective epitope within its sequence.

  1991cited by this paper
• Immune responses to defined epitopes of the circumsporozoite protein of the murine malaria parasite, Plasmodium yoelii

  1990cited by this paper
• Structure of the gene encoding the circumsporozoite protein of Plasmodium yoelii. A rodent model for examining antimalarial sporozoite vaccines.

  1987cited by this paper
• Synthetic peptide vaccine confers protection against murine malaria

  1987cited by this paper
• Protein-specific helper T-lymphocyte formation initiated by dendritic cells.

  1985cited by this paper
• Relative efficacy of human monocytes and dendritic cells as accessory cells for T cell replication

  1983cited by this paper
• Hybridoma produces protective antibodies directed against the sporozoite stage of malaria parasite.

  1980cited by this paper
• Dendritic cells are accessory cells for the development of anti- trinitrophenyl cytotoxic T lymphocytes

  1980cited by this paper
• Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice.

  1978cited by this paper
• Analysis of the repertoire of anti‐NP antibodies in C57BL/6 mice by cell fusion. I. Characterization of antibody families in the primary and hyperimmune response

  1978cited by this paper
• The carrier effect in the secondary response to hapten‐protein conjugates. I. Measurement of the effect with transferred cells and objections to the local environment hypothesis

  1971cited by this paper
• CARRIER FUNCTION IN ANTI-HAPTEN IMMUNE RESPONSES

  1970cited by this paper
• THE REQUIREMENT OF MORE THAN ONE ANTIGENIC DETERMINANT FOR IMMUNOGENICITY

  1969cited by this paper
• STUDIES ON THE EFFECT OF THE CARRIER MOLECULE ON ANTIHAPTEN ANTIBODY SYNTHESIS

  1966cited by this paper

• Exploring the Potential of Medicinal Mushroom β-Glucans as a Natural Frontier in Prostate Cancer Treatment.

  2025cites this paper
• The Importance of Vaccines in Preventing Impending Alzheimer's Epidemic.

  2025cites this paper
• Splenic cDC1 efferocytosis and cross-presentation to CD8 T cells are promoted by GPR34 and lysophosphatidylserine

  2025cites this paper
• Biomimetic phosphorus dendrimer multi-epitope nanovaccine enhances humoral and cellular immune response against African swine fever virus

  2025cites this paper
• Transcriptome landscape of high and low responders to an inactivated COVID-19 vaccine after 4 months using single-cell sequencing

  2024cites this paper
• Enhancing cell-mediated immunity through dendritic cell activation: the role of Tri-GalNAc-modified PLGA-PEG nanoparticles encapsulating SR717

  2024cites this paper
• A Glycolipid-Peptide-Hapten Tricomponent Conjugate Vaccine Generates Durable Antihapten Antibody Responses in Mice.

  2024cites this paper
• CXCL13 promotes broad immune responses induced by circular RNA vaccines

  2024cites this paper
• Development and Evaluation of a Newcastle Disease Virus-like Particle Vaccine Expressing SARS-CoV-2 Spike Protein with Protease-Resistant and Stability-Enhanced Modifications

  2024cites this paper
• Recombinant antigen delivery to dendritic cells as a way to improve vaccine design

  2023cites this paper
• Heterologous DNA Prime- Subunit Protein Boost with Chikungunya Virus E2 Induces Neutralizing Antibodies and Cellular-Mediated Immunity

  2023cites this paper
• Promoting immunity with novel targeting antigen delivery vehicle based on bispecific nanobody.

  2023cites this paper
• Targeting the P10 Peptide in Maturing Dendritic Cells via the DEC205 Receptor In Vivo: A New Therapeutic Strategy against Paracoccidioidomycosis

  2023cites this paper
• New tools for immunologists: models of lymph node function from cells to tissues

  2023cites this paper
• Silent circulation of Chikungunya virus among pregnant women and newborns in the Western Brazilian Amazon before the first outbreak of chikungunya fever

  2022cites this paper
• Germinal center expansion but not plasmablast differentiation is proportional to peptide-MHCII density via CD40-CD40L signaling strength

  2022cites this paper
• Immunization with CSP and a RIG-I Agonist is Effective in Inducing a Functional and Protective Humoral Response Against Plasmodium

  2022cites this paper
• Antigen-derived peptides engage the ER stress sensor IRE1α to curb dendritic cell cross-presentation

  2022cites this paper
• STAT3 signaling modulates the immune response induced after antigen targeting to conventional type 1 dendritic cells through the DEC205 receptor

  2022cites this paper
• Antigen targeting to dendritic cells: Still a place in future immunotherapy?

  2022cites this paper
• A Vaccination with Boosted Cross Presentation by ER‐Targeted Antigen Delivery for Anti‐Tumor Immunotherapy

  2021cites this paper
• STAT6 signaling pathway controls germinal center responses promoted after antigen targeting to conventional type 2 dendritic cells

  2021cites this paper
• ADP-ribosylating adjuvant reveals plasticity in cDC1 cells that drive mucosal Th17 cell development and protection against influenza virus infection

  2021cites this paper
• Follicular dendritic cells restrict interleukin-4 availability in germinal centers and foster memory B cell generation.

  2021cites this paper
• The unexpected contribution of conventional type 1 dendritic cells in driving antibody responses

  2021cites this paper
• Antigen Delivery to DEC205+ Dendritic Cells Induces Immunological Memory and Protective Therapeutic Effects against HPV-Associated Tumors at Different Anatomical Sites

  2021cites this paper
• Fast antibody responses by immuno-targeting and nanotechnology strategies versus HBsAg vaccine

  2021cites this paper
• Delivery of nanoparticle antigens to antigen-presenting cells: from extracellular specific targeting to intracellular responsive presentation.

  2021cites this paper
• Advances in Oral Subunit Vaccine Design

  2020cites this paper
• Silk Fibroin Nanoadjuvant as a Promising Vaccine Carrier to Deliver the FimH-IutA Antigen for Urinary Tract Infection.

  2020cites this paper
• Conventional type 1 dendritic cells induce TH1, TH1‐like follicular helper T cells and regulatory T cells after antigen boost via DEC205 receptor

  2020cites this paper
• Intradermal Delivery of Dendritic Cell-Targeting Chimeric mAbs Genetically Fused to Type 2 Dengue Virus Nonstructural Protein 1

  2020cites this paper
• Live long and active: Polypeptide-mediated assembly of antibody variable fragments.

  2020cites this paper
• Emerging Promise of Immunotherapy for Alzheimer's Disease: A New Hope for the Development of Alzheimer's Vaccine.

  2020cites this paper
• Vaccine adjuvant activity of a TLR4-activating synthetic glycolipid by promoting autophagy

  2020cites this paper
• Tracking the Trajectory of Functional Humoral Immune Responses Following Acute HIV Infection

  2020cites this paper
• Controlling timing and location in vaccines

  2020cites this paper
• Marginal zone SIGN-R1+ macrophages are essential for the maturation of germinal center B cells in the spleen

  2020cites this paper
• Enhancing Immunity with Nanomedicine: Employing Nanoparticles to Harness the Immune System.

  2020cites this paper
• Harnessing the Complete Repertoire of Conventional Dendritic Cell Functions for Cancer Immunotherapy

  2020cites this paper
• São Paulo School of Advanced Sciences on Vaccines: an overview

  2020influential citation
• Anti-NS1 antibodies induced by immunization with dendritic cell targeted hybrid monoclonal antibodies do not induce platelet dysfunction

  2020cites this paper
• Env Exceptionalism: Why Are HIV-1 Env Glycoproteins Atypical Immunogens?

  2020cites this paper
• Murine myeloproliferative disorder as a consequence of impaired collaboration between dendritic cells and CD4 T cells.

  2019cites this paper
• Peptide-Based Vaccination for Antibody Responses Against HIV

  2019cites this paper
• Protein Amounts of the MYC Transcription Factor Determine Germinal Center B Cell Division Capacity.

  2019cites this paper
• Targeting Conventional Dendritic Cells to Fine-Tune Antibody Responses

  2019cites this paper
• The STING activator c-di-AMP exerts superior adjuvant properties than the formulation poly(I:C)/CpG after subcutaneous vaccination with soluble protein antigen or DEC-205-mediated antigen targeting to dendritic cells.

  2019cites this paper
• Transcriptional control of dendritic cell development and functions.

  2019cites this paper
• Antigen presentation by dendritic cells for B cell activation.

  2019cites this paper
• Targeting M2e to DEC-205 induces an enhanced serum antibody-dependent heterosubtypic protection against influenza A virus infection.

  2019cites this paper
• Promising Results from Alzheimer's Disease Passive Immunotherapy Support the Development of a Preventive Vaccine

  2019cites this paper
• HBs antigen and mannose loading on the surface of iron oxide nanoparticles in order to immuno-targeting: fabrication, characterization, cellular and humoral immunoassay

  2019cites this paper
• Poly(I:C) Potentiates T Cell Immunity to a Dendritic Cell Targeted HIV-Multiepitope Vaccine

  2019cites this paper
• Dendritic Cell Targeting Using a DNA Vaccine Induces Specific Antibodies and CD4+ T Cells to the Dengue Virus Envelope Protein Domain III

  2019cites this paper
• Construction and expression of a single-chain variable fragment antibody against chicken DEC 205 for targeting the bacterial expressed hemagglutinin-neuraminidase of Newcastle disease virus.

  2019cites this paper
• Directing pathogen-derived proteins to cells responsible for the immune response activation

  2018cites this paper
• Dendritic Cells in the Cross Hair for the Generation of Tailored Vaccines

  2018cites this paper
• The Nontoxic Cholera B Subunit Is a Potent Adjuvant for Intradermal DC-Targeted Vaccination

  2018cites this paper
• Targeted Delivery of Toxoplasma gondii Antigens to Dendritic Cells Promote Immunogenicity and Protective Efficiency against Toxoplasmosis

  2018cites this paper
• Germinal Center Selection and Affinity Maturation Require Dynamic Regulation of mTORC1 Kinase

  2017cites this paper
• Dendritic Cell Targeting Effectively Boosts T Cell Responses Elicited by an HIV Multiepitope DNA Vaccine

  2017cites this paper
• CpG Oligodeoxinucleotides and Flagellin Modulate the Immune Response to Antigens Targeted to CD8α+ and CD8α− Conventional Dendritic Cell Subsets

  2017cites this paper
• Dendritic cell-targeted porcine reproductive and respiratory syndrome virus (PRRSV) antigens adjuvanted with polyinosinic-polycytidylic acid (poly (I:C)) induced non-protective immune responses against heterologous type 2 PRRSV challenge in pigs.

  2017cites this paper
• Dendritic cell-based immunotherapy: a basic review and recent advances

  2017cites this paper
• The Toll like receptor 4 ligand cold-inducible RNA-binding protein as vaccination platform against cancer

  2017cites this paper
• Near-Infrared 1064 nm Laser Modulates Migratory Dendritic Cells To Augment the Immune Response to Intradermal Influenza Vaccine

  2017cites this paper
• The transcription factor Foxo1 controls germinal center B cell proliferation in response to T cell help

  2017influential citation
• DC subset–specific induction of T cell responses upon antigen uptake via Fcγ receptors in vivo

  2017influential citation
• Pre-clinical antigenicity studies of an innovative multivalent vaccine for human visceral leishmaniasis

  2017cites this paper
• In vivo targeting of protein antigens to dendritic cells using anti‐DEC‐205 single chain antibody improves HIV Gag specific CD4+ T cell responses protecting from airway challenge with recombinant vaccinia‐gag virus

  2017cites this paper
• + Subsequent Cytotoxic CD8 Antibodies but Are Not Essential for DEC-205 - Intradermally Injected Anti Dendritic Cells Transport + Skin Langerin

  2017cites this paper
• Effect of TLR ligands co-encapsulated with multiepitopic antigen in nanoliposomes targeted to human DCs via Fc receptor for cancer vaccines.

  2017cites this paper
• Enhancing vaccine antibody responses by targeting Clec9A on dendritic cells

  2017cites this paper
• Targeted antigen delivery to dendritic cells elicits robust antiviral T cell-mediated immunity in the liver

  2017cites this paper
• Investigating the Role of Lipopolysaccharide and Polyinosinic:Polycytidylic Acid in Boosting CD4 T cell Responses

  2017cites this paper
• Newcastle disease virus-like particles induce dendritic cell maturation and enhance viral-specific immune response

  2017cites this paper
• Lung cancer and β-glucans: review of potential therapeutic applications

  2017cites this paper
• Greater activation of peripheral T follicular helper cells following high dose influenza vaccine in older adults forecasts seroconversion.

  2017cites this paper
• The presence of T cell epitopes is important for induction of antibody responses against antigens directed to DEC205+ dendritic cells

  2016cites this paper
• Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies

  2016cites this paper
• UvA-DARE ( Digital Academic Repository ) HIV-1 envelope trimer fusion proteins and their applications

  2016cites this paper
• Dendritic cell targeted vaccines: Recent progresses and challenges

  2016cites this paper
• Functional Specialization of Dendritic Cell Subsets

  2016cites this paper
• Development of a more efficient hepatitis B virus vaccine by targeting hepatitis B virus preS to dendritic cells.

  2016cites this paper
• Critical roles of conventional dendritic cells in promoting T cell‐dependent hepatitis through regulating natural killer T cells

  2016cites this paper
• Development of a DNA vaccine inducing HIV-1 Gagp24-reactive T cells

  2016cites this paper
• Understanding natural herpes simplex virus immunity to inform next-generation vaccine design

  2016cites this paper
• Selection Dynamics in the Germinal Center During Antibody Affinity Maturation

  2016influential citation
• TAK1 deficiency in dendritic cells inhibits adaptive immunity in SRBC‐immunized C57BL/6 mice

  2016cites this paper
• Dendritic Cells and Their Multiple Roles during Malaria Infection

  2016cites this paper
• A Dendritic cell targeted vaccine induces long term HIV-specific immunity within the gastrointestinal tract

  2016cites this paper
• DNA Vaccines: How Much Have We Accomplished In The Last 25 Years?

  2015cites this paper
• T cell help controls the speed of the cell cycle in germinal center B cells

  2015cites this paper
• DNA vaccines encoding DEC205‐targeted antigens: immunity or tolerance?

  2015cites this paper
• Targeting Antigen to Clec9A Primes Follicular Th Cell Memory Responses Capable of Robust Recall

  2015cites this paper
• DEC205+ Dendritic Cell–Targeted Tolerogenic Vaccination Promotes Immune Tolerance in Experimental Autoimmune Arthritis

  2015cites this paper
• The varieties of immunological experience: of pathogens, stress, and dendritic cells.

  2015cites this paper
• Antibody-targeted vaccination to lung dendritic cells generates tissue-resident memory CD8 T cells that are highly protective against influenza virus infection

  2015cites this paper
• Capable of Robust Recall Follicular Th Cell Memory Responses Targeting Antigen to Clec9A Primes

  2015cites this paper